{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:24:44Z","timestamp":1792448684563,"version":"4.5.0"},"reference-count":124,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.molmed.2023.02.001","type":"journal-article","created":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T17:11:23Z","timestamp":1679332283000},"page":"390-405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["PARsylation-mediated ubiquitylation: lessons from rare hereditary disease Cherubism"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7047-2976","authenticated-orcid":false,"given":"Yoshinori","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Rottapel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2023.02.001_bb0005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1101\/gad.183509.111","article-title":"On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1","volume":"26","author":"Luo","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2023.02.001_bb0010","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.molcel.2017.01.003","article-title":"Serine ADP-ribosylation depends on HPF1","volume":"65","author":"Bonfiglio","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2023.02.001_bb0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1126\/science.aaf7865","article-title":"Chemical genetic discovery of PARP targets reveals a role for PARP-1 in transcription elongation","volume":"353","author":"Gibson","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.molmed.2023.02.001_bb0020","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3390\/cells8091047","article-title":"The role of PARPs in inflammation-and metabolic-related diseases: molecular mechanisms and beyond","volume":"8","author":"Ke","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.molmed.2023.02.001_bb0025","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1111\/febs.13737","article-title":"New directions in poly(ADP-ribose) polymerase biology","volume":"283","author":"Bock","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.molmed.2023.02.001_bb0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1101\/gad.291518.116","article-title":"PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes","volume":"31","author":"Gupte","year":"2017","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2023.02.001_bb0035","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrm3376","article-title":"New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs","volume":"13","author":"Gibson","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0040","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.cell.2011.10.045","article-title":"Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism","volume":"147","author":"Levaot","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2023.02.001_bb0045","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.cell.2011.10.046","article-title":"Structural basis and sequence rules for substrate recognition by Tankyrase explain the basis for cherubism disease","volume":"147","author":"Guettler","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2023.02.001_bb0050","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/ncb2222","article-title":"RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling","volume":"13","author":"Zhang","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0055","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1302\/0301-620X.32B3.334","article-title":"Cherubism--familial fibrous dysplasia of the jaws","volume":"32-B","author":"Jones","year":"1950","journal-title":"J. Bone Joint Surg. Br."},{"key":"10.1016\/j.molmed.2023.02.001_bb0060","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.8438166","article-title":"Identification of a ten-amino acid proline-rich SH3 binding site","volume":"259","author":"Ren","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.molmed.2023.02.001_bb0065","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1126\/science.1379745","article-title":"Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho","volume":"257","author":"Cicchetti","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.molmed.2023.02.001_bb0070","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/0-387-34132-3_8","article-title":"The adapter 3BP2: how it plugs into leukocyte signaling","volume":"584","author":"Deckert","year":"2006","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0075","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1172\/JCI45843","article-title":"3BP2-deficient mice are osteoporotic with impaired osteoblast and osteoclast functions","volume":"121","author":"Levaot","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2023.02.001_bb0080","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1172\/JCI87802","article-title":"Reciprocal stabilization of ABL and TAZ regulates osteoblastogenesis through transcription factor RUNX2","volume":"126","author":"Matsumoto","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2023.02.001_bb0085","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1086\/302456","article-title":"The gene for cherubism maps to chromosome 4p16","volume":"65","author":"Tiziani","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2023.02.001_bb0090","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1086\/302454","article-title":"The gene for cherubism maps to chromosome 4p16.3","volume":"65","author":"Mangion","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2023.02.001_bb0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/88832","article-title":"Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism","volume":"28","author":"Ueki","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2023.02.001_bb0100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cell.2006.10.047","article-title":"Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 \u2018cherubism\u2019 mice","volume":"128","author":"Ueki","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2023.02.001_bb0105","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1126\/science.282.5393.1484","article-title":"Tankyrase, a poly(ADP-ribose) polymerase at human telomeres","volume":"282","author":"Smith","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.molmed.2023.02.001_bb0110","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1101\/gad.1077103","article-title":"TRF1 is degraded by ubiquitin-mediated proteolysis after release from telomeres","volume":"17","author":"Chang","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2023.02.001_bb0115","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0960-9822(00)00752-1","article-title":"Tankyrase promotes telomere elongation in human cells","volume":"10","author":"Smith","year":"2000","journal-title":"Curr. Biol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0120","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1038\/sj.emboj.7601903","article-title":"Protein requirements for sister telomere association in human cells","volume":"26","author":"Canudas","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2023.02.001_bb0125","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.2174\/1381612820666140630101525","article-title":"Tankyrases: structure, function and therapeutic implications in cancer","volume":"20","author":"Haikarainen","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.molmed.2023.02.001_bb0130","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1128\/MCB.26.6.2044-2054.2006","article-title":"Tankyrase 2 poly(ADP-ribose) polymerase domain-deleted mice exhibit growth defects but have normal telomere length and capping","volume":"26","author":"Hsiao","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0135","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1128\/MCB.26.6.2037-2043.2006","article-title":"Generation and characterization of telomere length maintenance in tankyrase 2-deficient mice","volume":"26","author":"Chiang","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0140","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.2337\/db08-1781","article-title":"Hypermetabolism, hyperphagia, and reduced adiposity in tankyrase-deficient mice","volume":"58","author":"Yeh","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.molmed.2023.02.001_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002639","article-title":"Tankyrase 1 and tankyrase 2 are essential but redundant for mouse embryonic development","volume":"3","author":"Chiang","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2023.02.001_bb0150","doi-asserted-by":"crossref","first-page":"35891","DOI":"10.1074\/jbc.M105968200","article-title":"TANK2, a new TRF1-associated poly(ADP-ribose) polymerase, causes rapid induction of cell death upon overexpression","volume":"276","author":"Kaminker","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2023.02.001_bb0155","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1042\/bj20021450","article-title":"Vertebrate tankyrase domain structure and sterile alpha motif (SAM)-mediated multimerization","volume":"372","author":"De Rycker","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.molmed.2023.02.001_bb0160","doi-asserted-by":"crossref","first-page":"9802","DOI":"10.1128\/MCB.24.22.9802-9812.2004","article-title":"Tankyrase polymerization is controlled by its sterile alpha motif and poly(ADP-ribose) polymerase domains","volume":"24","author":"De Rycker","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0165","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.biochi.2007.07.012","article-title":"Tankyrase function at telomeres, spindle poles, and beyond","volume":"90","author":"Hsiao","year":"2008","journal-title":"Biochimie"},{"key":"10.1016\/j.molmed.2023.02.001_bb0170","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13046-021-01950-6","article-title":"Tankyrases as modulators of pro-tumoral functions: molecular insights and therapeutic opportunities","volume":"40","author":"Zamudio-Martinez","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.molmed.2023.02.001_bb0175","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/pro.2968","article-title":"Structural insights into SAM domain-mediated tankyrase oligomerization","volume":"25","author":"DaRosa","year":"2016","journal-title":"Protein Sci."},{"key":"10.1016\/j.molmed.2023.02.001_bb0180","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1016\/j.febslet.2012.09.009","article-title":"Structural insight into the interaction of ADP-ribose with the PARP WWE domains","volume":"586","author":"He","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.molmed.2023.02.001_bb0185","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1101\/gad.182618.111","article-title":"Recognition of the iso-ADP-ribose moiety in poly(ADP-ribose) by WWE domains suggests a general mechanism for poly(ADP-ribosyl)ation-dependent ubiquitination","volume":"26","author":"Wang","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2023.02.001_bb0190","doi-asserted-by":"crossref","first-page":"14103","DOI":"10.1073\/pnas.1108799108","article-title":"Iduna is a poly(ADP-ribose) (PAR)-dependent E3 ubiquitin ligase that regulates DNA damage","volume":"108","author":"Kang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2023.02.001_bb0195","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nature13826","article-title":"Allosteric activation of the RNF146 ubiquitin ligase by a poly(ADP-ribosyl)ation signal","volume":"517","author":"DaRosa","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2023.02.001_bb0200","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/pro.3413","article-title":"Structural basis for tankyrase-RNF146 interaction reveals noncanonical tankyrase-binding motifs","volume":"27","author":"DaRosa","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.molmed.2023.02.001_bb0205","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1172\/JCI90527","article-title":"RANKL coordinates multiple osteoclastogenic pathways by regulating expression of ubiquitin ligase RNF146","volume":"127","author":"Matsumoto","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2023.02.001_bb0210","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1083\/jcb.201207142","article-title":"Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin","volume":"200","author":"Albers","year":"2013","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0215","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.4049\/jimmunol.1102836","article-title":"TREM2 and beta-catenin regulate bone homeostasis by controlling the rate of osteoclastogenesis","volume":"188","author":"Otero","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0220","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1128\/MCB.05980-11","article-title":"Biphasic and dosage-dependent regulation of osteoclastogenesis by beta-catenin","volume":"31","author":"Wei","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0225","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/jmg.36.3.177","article-title":"Cleidocranial dysplasia: clinical and molecular genetics","volume":"36","author":"Mundlos","year":"1999","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.molmed.2023.02.001_bb0230","first-page":"835","article-title":"Sur la dysostose cl\u00e9ido-cranienne h\u00e9r\u00e9ditaire","volume":"6","author":"Marie","year":"1898","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0235","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1172\/JCI92233","article-title":"Ubiquitin ligase RNF146 coordinates bone dynamics and energy metabolism","volume":"127","author":"Matsumoto","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2023.02.001_bb0240","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0092-8674(00)80260-3","article-title":"Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia","volume":"89","author":"Mundlos","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2023.02.001_bb0245","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/ng0797-307","article-title":"Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2\/CBFA1 in cleidocranial dysplasia","volume":"16","author":"Lee","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2023.02.001_bb0250","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-62703-989-5_1","article-title":"Overview of skeletal development","volume":"1130","author":"Kobayashi","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0255","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0092-8674(00)80257-3","article-title":"Osf2\/Cbfa1: a transcriptional activator of osteoblast differentiation","volume":"89","author":"Ducy","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2023.02.001_bb0260","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0092-8674(00)80258-5","article-title":"Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts","volume":"89","author":"Komori","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2023.02.001_bb0265","doi-asserted-by":"crossref","first-page":"E1587","DOI":"10.1002\/humu.21298","article-title":"Deletions of the RUNX2 gene are present in about 10% of individuals with cleidocranial dysplasia","volume":"31","author":"Ott","year":"2010","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.molmed.2023.02.001_bb0270","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","article-title":"Endocrine regulation of energy metabolism by the skeleton","volume":"130","author":"Lee","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2023.02.001_bb0275","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/dbio.1996.8487","article-title":"SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse","volume":"183","author":"Ng","year":"1997","journal-title":"Dev. Biol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0280","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.1093\/emboj\/17.19.5718","article-title":"A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene","volume":"17","author":"Lefebvre","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2023.02.001_bb0285","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ng0195-15","article-title":"The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos","volume":"9","author":"Wright","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2023.02.001_bb0290","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1038\/s41467-019-12910-2","article-title":"Tankyrase inhibition preserves osteoarthritic cartilage by coordinating cartilage matrix anabolism via effects on SOX9 PARylation","volume":"10","author":"Kim","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2023.02.001_bb0295","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1074-7613(00)80119-3","article-title":"Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components","volume":"11","author":"Takeuchi","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2023.02.001_bb0300","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2023.02.001_bb0305","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/CMR.00046-08","article-title":"Pathogen recognition and inflammatory signaling in innate immune defenses","volume":"22","author":"Mogensen","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.molmed.2023.02.001_bb0310","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.celrep.2014.08.023","article-title":"Enhanced TLR-MYD88 signaling stimulates autoinflammation in SH3BP2 cherubism mice and defines the etiology of cherubism","volume":"8","author":"Yoshitaka","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2023.02.001_bb0315","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1172\/JCI71081","article-title":"Cherubism allele heterozygosity amplifies microbe-induced inflammatory responses in murine macrophages","volume":"125","author":"Prod'Homme","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2023.02.001_bb0320","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140869","article-title":"Tankyrase represses autoinflammation through the attenuation of TLR2 signaling","volume":"132","author":"Matsumoto","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2023.02.001_bb0615","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.4049\/jimmunol.1103184","article-title":"The 3BP2 adapter protein is required for chemoattractant-mediated neutrophil activation","volume":"189","author":"Chen","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0325","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1073\/pnas.88.13.5582","article-title":"G alpha 12 and G alpha 13 subunits define a fourth class of G protein alpha subunits","volume":"88","author":"Strathmann","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2023.02.001_bb0330","first-page":"2777","article-title":"Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps\/fes, GRB-2, HCP, SHC, Syk, and Vav","volume":"14","author":"Songyang","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0335","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1074-7613(02)00426-0","article-title":"The physiologic role of CD19 cytoplasmic tyrosines","volume":"17","author":"Wang","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2023.02.001_bb0340","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1128\/MCB.01014-06","article-title":"The 3BP2 adapter protein is required for optimal B-cell activation and thymus-independent type 2 humoral response","volume":"27","author":"Chen","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0345","first-page":"763","article-title":"Expression of the mucosal vascular addressin, MAdCAM-1, on sinus-lining cells in the spleen","volume":"147","author":"Kraal","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0350","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/eji.1830161216","article-title":"Differences in the recruitment of virgin B cells into antibody responses to thymus-dependent and thymus-independent type-2 antigens","volume":"16","author":"Lane","year":"1986","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0355","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1600-065X.2000.imr017515.x","article-title":"B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a \u2018natural immune memory\u2019","volume":"175","author":"Martin","year":"2000","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molmed.2023.02.001_bb0360","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1074-7613(00)80657-3","article-title":"Adaptor function for the Syk kinases-interacting protein 3BP2 in IL-2 gene activation","volume":"9","author":"Deckert","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2023.02.001_bb0365","doi-asserted-by":"crossref","first-page":"33719","DOI":"10.1074\/jbc.M109.049999","article-title":"Tyrosine phosphorylation of 3BP2 regulates B cell receptor-mediated activation of NFAT","volume":"284","author":"Shukla","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2023.02.001_bb0620","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.celrep.2018.06.075","article-title":"Timed regulation of 3BP2 induction is critical for sustaining CD8+ T cell expansion and differentiation","volume":"24","author":"Dimitriou","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2023.02.001_bb0370","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/87720","article-title":"Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells","volume":"2","author":"Kaech","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0375","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/87730","article-title":"Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation","volume":"2","author":"van Stipdonk","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0380","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fimmu.2016.00076","article-title":"T cells and gene regulation: the switching on and turning up of genes after T cell receptor stimulation in CD8 T cells","volume":"7","author":"Conley","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0385","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/imr.12010","article-title":"Super-resolution characterization of TCR-dependent signaling clusters","volume":"251","author":"Sherman","year":"2013","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molmed.2023.02.001_bb0390","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0092-8674(00)80324-4","article-title":"The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation","volume":"90","author":"Zeng","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2023.02.001_bb0395","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1111\/febs.12320","article-title":"Tankyrases as drug targets","volume":"280","author":"Lehtio","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.molmed.2023.02.001_bb0400","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0898-6568(99)00054-6","article-title":"Roles of Axin in the Wnt signalling pathway","volume":"11","author":"Kikuchi","year":"1999","journal-title":"Cell. Signal."},{"key":"10.1016\/j.molmed.2023.02.001_bb0405","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.str.2016.07.014","article-title":"Tankyrase-1 ankyrin repeats form an adaptable binding platform for targets of ADP-ribose modification","volume":"24","author":"Eisemann","year":"2016","journal-title":"Structure"},{"key":"10.1016\/j.molmed.2023.02.001_bb0410","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1073\/pnas.1116618109","article-title":"Crystal structure of a Tankyrase-Axin complex and its implications for Axin turnover and Tankyrase substrate recruitment","volume":"109","author":"Morrone","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2023.02.001_bb0415","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/nature08356","article-title":"Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling","volume":"461","author":"Huang","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2023.02.001_bb0420","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1101\/gad.251785.114","article-title":"Poly-ADP ribosylation of PTEN by tankyrases promotes PTEN degradation and tumor growth","volume":"29","author":"Li","year":"2015","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2023.02.001_bb0425","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1242\/dev.045500","article-title":"Hippo signaling: growth control and beyond","volume":"138","author":"Halder","year":"2011","journal-title":"Development"},{"key":"10.1016\/j.molmed.2023.02.001_bb0430","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.devcel.2010.09.011","article-title":"The hippo signaling pathway in development and cancer","volume":"19","author":"Pan","year":"2010","journal-title":"Dev. Cell"},{"key":"10.1016\/j.molmed.2023.02.001_bb0435","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1101\/gad.1909210","article-title":"The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version","volume":"24","author":"Zhao","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2023.02.001_bb0440","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ccr.2014.01.010","article-title":"A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer","volume":"25","author":"Jiao","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2023.02.001_bb0445","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cell.2014.06.003","article-title":"Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer","volume":"158","author":"Kapoor","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2023.02.001_bb0450","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/cr.2014.10","article-title":"VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex","volume":"24","author":"Zhang","year":"2014","journal-title":"Cell Res."},{"key":"10.1016\/j.molmed.2023.02.001_bb0455","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1074\/jbc.C110.212621","article-title":"Hippo pathway-independent restriction of TAZ and YAP by angiomotin","volume":"286","author":"Chan","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2023.02.001_bb0460","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1074\/jbc.C110.205401","article-title":"Angiomotin-like proteins associate with and negatively regulate YAP1","volume":"286","author":"Wang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2023.02.001_bb0465","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1101\/gad.2000111","article-title":"Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein","volume":"25","author":"Zhao","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2023.02.001_bb0470","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.celrep.2015.09.014","article-title":"Tankyrase inhibitors target YAP by stabilizing angiomotin family proteins","volume":"13","author":"Wang","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2023.02.001_bb0475","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1038\/s41467-019-12377-1","article-title":"Tankyrase disrupts metabolic homeostasis and promotes tumorigenesis by inhibiting LKB1\u2013AMPK signalling","volume":"10","author":"Li","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2023.02.001_bb0480","doi-asserted-by":"crossref","first-page":"10502","DOI":"10.1016\/S0021-9258(19)70491-8","article-title":"Poly(ADP-ribose) synthesis in vitro programmed by damaged DNA. A comparison of DNA molecules containing different types of strand breaks","volume":"255","author":"Benjamin","year":"1980","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2023.02.001_bb0485","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1021\/bi00189a012","article-title":"Dual function for poly(ADP-ribose) synthesis in response to DNA strand breakage","volume":"33","author":"Satoh","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.molmed.2023.02.001_bb0490","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrclinonc.2014.163","article-title":"An update on PARP inhibitors--moving to the adjuvant setting","volume":"12","author":"Sonnenblick","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0495","doi-asserted-by":"crossref","DOI":"10.1177\/1758835919849753","article-title":"Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer","volume":"11","author":"Ledermann","year":"2019","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0500","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMoa1105535","article-title":"Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer","volume":"366","author":"Ledermann","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2023.02.001_bb0505","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201846166","article-title":"Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA\u2013damaging chemotherapeutic agents","volume":"20","author":"Hu","year":"2019","journal-title":"EMBO Rep."},{"key":"10.1016\/j.molmed.2023.02.001_bb0510","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/13543776.2021.1888929","article-title":"Tankyrase inhibitors as antitumor agents: a patent update (2013 - 2020)","volume":"31","author":"Mehta","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.molmed.2023.02.001_bb0515","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/art.38975","article-title":"Loss of SH3 domain-binding protein 2 function suppresses bone destruction in tumor necrosis factor-driven and collagen-induced arthritis in mice","volume":"67","author":"Mukai","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0520","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1002\/jbmr.2295","article-title":"SH3BP2 cherubism mutation potentiates TNF-alpha-induced osteoclastogenesis via NFATc1 and TNF-alpha-mediated inflammatory bone loss","volume":"29","author":"Mukai","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2023.02.001_bb0525","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105518","article-title":"SH3BP2 gain-of-function mutation exacerbates inflammation and bone loss in a murine collagen-induced arthritis model","volume":"9","author":"Mukai","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2023.02.001_bb0530","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.3390\/ijms22084169","article-title":"SH3BP2 deficiency ameliorates murine systemic lupus erythematosus","volume":"22","author":"Kawahara","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2023.02.001_bb0535","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jcmgh.2021.08.004","article-title":"SYK-3BP2 pathway activity in parenchymal and myeloid cells is a key pathogenic factor in metabolic steatohepatitis","volume":"13","author":"Luci","year":"2022","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0540","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2122805119","article-title":"Tankyrases inhibit innate antiviral response by PARylating VISA\/MAVS and priming it for RNF146\u2013mediated ubiquitination and degradation","volume":"119","author":"Xu","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2023.02.001_bb0545","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.245811","article-title":"TDP-43, a protein central to amyotrophic lateral sclerosis, is destabilized by tankyrase-1 and -2","volume":"133","author":"McGurk","year":"2020","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.molmed.2023.02.001_bb0550","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.celrep.2017.06.077","article-title":"Proteomic analysis of the human tankyrase protein interaction network reveals its role in pexophagy","volume":"20","author":"Li","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2023.02.001_bb0555","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1038\/s41467-017-02363-w","article-title":"Whole proteome analysis of human tankyrase knockout cells reveals targets of tankyrase-mediated degradation","volume":"8","author":"Bhardwaj","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2023.02.001_bb0560","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202008037","article-title":"Tankyrase regulates epithelial lumen formation via suppression of Rab11 GEFs","volume":"220","author":"Chandrakumar","year":"2021","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0565","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.celrep.2018.09.036","article-title":"Tankyrase mediates K63-linked ubiquitination of JNK to confer stress tolerance and influence lifespan in Drosophila","volume":"25","author":"Li","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2023.02.001_bb0570","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1021\/jacs.6b10234","article-title":"Macrocyclized extended peptides: inhibiting the substrate-recognition domain of tankyrase","volume":"139","author":"Xu","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.molmed.2023.02.001_bb0575","article-title":"Pharmacologic inhibition of PARP5, but not that of PARP1 or 2, promotes cytokine production and osteoclastogenesis through different pathways","author":"Asano","year":"2023","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0580","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.3390\/ijms23052834","article-title":"Tankyrase regulates neurite outgrowth through poly(ADP-ribosyl)ation-dependent activation of beta-catenin signaling","volume":"23","author":"Mashimo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2023.02.001_bb0585","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2023.02.001_bb0590","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1128\/MCB.00258-12","article-title":"GDP-mannose-4,6-dehydratase is a cytosolic partner of tankyrase 1 that inhibits its poly(ADP-ribose) polymerase activity","volume":"32","author":"Bisht","year":"2012","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050457","article-title":"WIKI4, a novel inhibitor of tankyrase and Wnt\/ss\u2013catenin signaling","volume":"7","author":"James","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2023.02.001_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107922","article-title":"Tissue-specific regulation of the Wnt\/beta-catenin pathway by PAGE4 inhibition of tankyrase","volume":"32","author":"Koirala","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2023.02.001_bb0605","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1128\/MCB.01094-10","article-title":"The ubiquitin-specific protease USP34 regulates axin stability and Wnt\/beta-catenin signaling","volume":"31","author":"Lui","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2023.02.001_bb0610","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41586-022-05449-8","article-title":"Structural basis of tankyrase activation by polymerization","volume":"612","author":"Pillay","year":"2022","journal-title":"Nature"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491423000321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491423000321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:27:26Z","timestamp":1761463646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491423000321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":124,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1471491423000321"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2023.02.001","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PARsylation-mediated ubiquitylation: lessons from rare hereditary disease Cherubism","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2023.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}